Global Health Limited (MEDANTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Global Health Limited (MEDANTA) has a cash flow conversion efficiency ratio of 0.089x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.29 Billion ≈ $35.53 Million USD) by net assets (Rs37.10 Billion ≈ $401.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDANTA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Global Health Limited - Cash Flow Conversion Efficiency Trend (2019–2026)
This chart illustrates how Global Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Global Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Global Health Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanmi Pharm Co Ltd
KO:128940
|
0.031x |
|
CleanSpark Inc
NASDAQ:CLSK
|
-0.163x |
|
Edgewise Therapeutics Inc
NASDAQ:EWTX
|
-0.086x |
|
Monday.Com Ltd
NASDAQ:MNDY
|
0.138x |
|
ENAGAS A.A. ADR1/2/EO150
F:EG40
|
0.014x |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
0.025x |
|
Bullish
NYSE:BLSH
|
0.029x |
|
CGN Power Co Ltd
F:94C
|
0.064x |
Annual Cash Flow Conversion Efficiency for Global Health Limited (2019–2026)
The table below shows the annual cash flow conversion efficiency of Global Health Limited from 2019 to 2026. For the full company profile with market capitalisation and key ratios, see market cap of Global Health Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs39.84 Billion ≈ $430.88 Million |
Rs7.53 Billion ≈ $81.45 Million |
0.189x | +2.66% |
| 2025-03-31 | Rs33.88 Billion ≈ $366.35 Million |
Rs6.24 Billion ≈ $67.46 Million |
0.184x | -12.59% |
| 2024-03-31 | Rs29.06 Billion ≈ $314.23 Million |
Rs6.12 Billion ≈ $66.19 Million |
0.211x | -20.64% |
| 2023-03-31 | Rs24.28 Billion ≈ $262.60 Million |
Rs6.45 Billion ≈ $69.70 Million |
0.265x | +37.81% |
| 2022-03-31 | Rs16.16 Billion ≈ $174.77 Million |
Rs3.11 Billion ≈ $33.66 Million |
0.193x | +10.13% |
| 2021-03-31 | Rs13.82 Billion ≈ $149.50 Million |
Rs2.42 Billion ≈ $26.15 Million |
0.175x | +34.82% |
| 2020-03-31 | Rs13.50 Billion ≈ $145.95 Million |
Rs1.75 Billion ≈ $18.93 Million |
0.130x | +11.84% |
| 2019-03-31 | Rs13.31 Billion ≈ $143.93 Million |
Rs1.54 Billion ≈ $16.69 Million |
0.116x | -- |
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more